Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433914
Status:
COMPLETED
Last Update Posted:
2015-03-06
First Post:
2007-02-09
Brief Title:
Safety Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine When Administered to Healthy Infants
Sponsor:
Novartis Vaccines
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
V72P9
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Vaccines
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None